InVivo Therapeutics Holdings CEO Richard Toselli's 2022 pay slips 11% to $960K
InVivo Therapeutics Holdings reports 2022 executive compensation
By ExecPay News
Published: December 5, 2023
InVivo Therapeutics Holdings reported fiscal year 2022 executive compensation information on December 5, 2023.
In 2022, three executives at InVivo Therapeutics Holdings received on average a compensation package of $673K, a 24% decrease compared to previous year.
Average pay of disclosed executives at InVivo Therapeutics Holdings
Richard Toselli, Chief Executive Officer, received $960K in total, which decreased by 11% compared to 2021. 56% of Toselli's compensation, or $537K, was in salary. Toselli also received $269K in bonus, $135K in option awards, as well as $19K in other compensation.
Richard Christopher, Chief Financial Officer, received a compensation package of $584K, which decreased by 16% compared to previous year. 63% of the compensation package, or $369K, was in salary.
Heather Hamel, Chief Legal Officer, earned $477K in 2022.
Related executives
You may also like
Source: SEC filing on December 5, 2023.